223 related articles for article (PubMed ID: 36029014)
1. Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors.
Jaragh-Alhadad L; Behbehani H; Karnik S
Drug Deliv; 2022 Dec; 29(1):2759-2772. PubMed ID: 36029014
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers.
Jaragh-Alhadad L; Samir M; Harford TJ; Karnik S
Drug Deliv; 2022 Dec; 29(1):2206-2216. PubMed ID: 35815732
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
[TBL] [Abstract][Full Text] [Related]
5. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
[TBL] [Abstract][Full Text] [Related]
6. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
7. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
[TBL] [Abstract][Full Text] [Related]
8. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
Kader A; Pater A
J Control Release; 2002 Apr; 80(1-3):29-44. PubMed ID: 11943385
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Zhang X; Huang G
Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.
Saad EA; Waly HM
Cancer Chemother Pharmacol; 2019 Apr; 83(4):649-658. PubMed ID: 30648201
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of anticancer drug curcumin and co-loading with photosensitizer hypericin into lipoproteins investigated by fluorescence resonance energy transfer.
Jutkova A; Chorvat D; Miskovsky P; Jancura D; Datta S
Int J Pharm; 2019 Jun; 564():369-378. PubMed ID: 31022501
[TBL] [Abstract][Full Text] [Related]
14. Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure-activity relationship, in vitro and in vivo evaluation as antitumor agents.
Islam F; Quadery TM; Bai R; Luckett-Chastain LR; Hamel E; Ihnat MA; Gangjee A
Bioorg Med Chem Lett; 2021 Jun; 41():127923. PubMed ID: 33705908
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein decorated and indocyanine green loaded silica nanoparticles for tumor-targeted photothermal therapy of breast cancer.
Pan H; Sun Y; Cao D; Wang L
Pharm Dev Technol; 2020 Mar; 25(3):308-315. PubMed ID: 31820663
[TBL] [Abstract][Full Text] [Related]
16. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
[TBL] [Abstract][Full Text] [Related]
17. In-vitro anticancer and antimicrobial activities of PLGA/silver nanofiber composites prepared by electrospinning.
Almajhdi FN; Fouad H; Khalil KA; Awad HM; Mohamed SH; Elsarnagawy T; Albarrag AM; Al-Jassir FF; Abdo HS
J Mater Sci Mater Med; 2014 Apr; 25(4):1045-53. PubMed ID: 24375170
[TBL] [Abstract][Full Text] [Related]
18. Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.
Zhu C; Xia Y
Chem Soc Rev; 2017 Dec; 46(24):7668-7682. PubMed ID: 29104991
[TBL] [Abstract][Full Text] [Related]
19. Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.
Voruganti S; Qin JJ; Sarkar S; Nag S; Walbi IA; Wang S; Zhao Y; Wang W; Zhang R
Oncotarget; 2015 Aug; 6(25):21379-94. PubMed ID: 26041888
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
